Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
58,551,187
-
Share change
-
+6,525
-
Total reported value
-
$546,896,729
-
Put/Call ratio
-
17%
-
Price per share
-
$9.34
-
Number of holders
-
116
-
Value change
-
-$98,955
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q4 2013
As of 31 Dec 2013,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,551,187 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, State Street Corp, BB Biotech AG, ORBIMED ADVISORS LLC, BlackRock Fund Advisors, Visium Asset Management, LP, FRANKLIN RESOURCES INC, and BlackRock Institutional Trust Company, N.A..
This page lists
116
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.